DDrare: Database of Drug Development for Rare Diseases

Rexlemestrocel-l (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
210	Single Ventricle	1
211	Hypoplastic left heart syndrome	1

210. Single Ventricle [ 47 clinical trials, 54 drugs, (DrugBank: 23 drugs), 32 drug target genes, 66 drug target pathways]

Searched query = "Single Ventricle", "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 47 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03079401 (ClinicalTrials.gov)	November 27, 2017	8/3/2017	Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Hypoplastic Left Heart Syndrome;Atrioventricular Canal	Biological: MPC; rexlemestrocel-L	Boston Children's Hospital	NULL	Recruiting	N/A	5 Years	All	24	Phase 1;Phase 2	United States

211. Hypoplastic left heart syndrome [ 20 clinical trials, 28 drugs, (DrugBank: 9 drugs), 5 drug target genes, 13 drug target pathways]

Searched query = "Hypoplastic left heart syndrome", "HLHS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 20 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03079401 (ClinicalTrials.gov)	November 27, 2017	8/3/2017	Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle	Hypoplastic Left Heart Syndrome;Atrioventricular Canal	Biological: MPC; rexlemestrocel-L	Boston Children's Hospital	NULL	Recruiting	N/A	5 Years	All	24	Phase 1;Phase 2	United States